Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion

1989 ◽  
Vol 96 (4) ◽  
pp. 1158-1164 ◽  
Author(s):  
Guido Adler ◽  
Max Reinshagen ◽  
Irmtraut Koop ◽  
Burkhard Göke ◽  
Anton Schafmayer ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Pancreatic Secretion ◽  
Differential Effects ◽  
Cholecystokinin Receptor

Effect of a Novel Cholecystokinin Receptor Antagonist, FK480, Administered Intraduodenally, on Pancreatic Secretion in Rats

Pancreas ◽  
1995 ◽  
Vol 10 (3) ◽  
pp. 295-300 ◽  
Author(s):  
Yuriko Moriyoshi ◽  
Keiko Shiratori ◽  
Tadashi Takeuchi ◽  
Shin-ichiro Watanabe
Keyword(s):  
Receptor Antagonist ◽  
Pancreatic Secretion ◽  
Cholecystokinin Receptor

Cholecystokinin Receptor Antagonist Loxiglumide: Influence on Bilio-Pancreatic Secretion and Gastrointestinal Hormones in Man

Digestion ◽  
1990 ◽  
Vol 46 (2) ◽  
pp. 232-239 ◽  
Author(s):  
Wolfgang E. Schmidt ◽  
Werner Creutzfeldt ◽  
Michael Höcker ◽  
Anjona Roy Choudhury ◽  
Rainer Nustede ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Pancreatic Secretion ◽  
Gastrointestinal Hormones ◽  
Cholecystokinin Receptor

scholarly journals A synthetic peptide derivative that is a cholecystokinin receptor antagonist.

1987 ◽  
Vol 262 (15) ◽  
pp. 7226-7231 ◽  
Author(s):  
M F Lignon ◽  
M C Galas ◽  
M Rodriguez ◽  
J Laur ◽  
A Aumelas ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Synthetic Peptide ◽  
Cholecystokinin Receptor ◽  
Peptide Derivative

The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans

1992 ◽  
Vol 102 (5) ◽  
pp. 1742-1751 ◽  
Author(s):  
Per Cantor ◽  
Poul Erik Mortensen ◽  
John Myhre ◽  
Ida Gjorup ◽  
Helge Worning ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Cholecystokinin Receptor

scholarly journals Cholecystokinin Receptor Antagonist Halts Progression of Pancreatic Cancer Precursor Lesions and Fibrosis in Mice

Pancreas ◽  
2014 ◽  
Vol 43 (7) ◽  
pp. 1050-1059 ◽  
Author(s):  
Jill P. Smith ◽  
Timothy K. Cooper ◽  
Christopher O. McGovern ◽  
Evan L. Gilius ◽  
Qing Zhong ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Receptor Antagonist ◽  
Precursor Lesions ◽  
Cholecystokinin Receptor

Bombesin Reduces Food Intake after a Preload in Man by a Cholecystokinin-Independent Mechanism

1993 ◽  
Vol 85 (3) ◽  
pp. 277-280 ◽  
Author(s):  
R. J. Lieverse ◽  
J. B. M. J. Jansen ◽  
A. A. M. Masclee ◽  
C. B. H. W. Lamers
Keyword(s):  
Food Intake ◽  
Receptor Antagonist ◽  
Healthy Subjects ◽  
Saline Infusion ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Cholecystokinin Receptor ◽  
Independent Mechanism

1. A double-blind study was undertaken to determine whether the infusion of bombesin inhibits the intake of a carbohydrate-rich meal, consumed 15 min after a 300 ml banana shake, in nine lean healthy subjects and whether the possible inhibition of food intake by bombesin is mediated by cholecystokinin. 2. The amount of food eaten during infusion of bombesin (267 ±60 g) and bombesin combined with the cholecystokinin-receptor antagonist loxiglumide (269±39g) was slightly (P = 0.09) less than during saline infusion (384 ± 40 g). In addition, preprandial feelings of hunger were significantly less during infusion of both bombesin and bombesin combined with loxiglumide. 3. In conclusion, infusion of bombesin tends to inhibit the intake of a carbohydrate-rich meal after a preload by a cholecystokinin-independent mechanism.

Sign in / Sign up

Export Citation Format

Share Document